JP2020502058A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502058A5 JP2020502058A5 JP2019526217A JP2019526217A JP2020502058A5 JP 2020502058 A5 JP2020502058 A5 JP 2020502058A5 JP 2019526217 A JP2019526217 A JP 2019526217A JP 2019526217 A JP2019526217 A JP 2019526217A JP 2020502058 A5 JP2020502058 A5 JP 2020502058A5
- Authority
- JP
- Japan
- Prior art keywords
- indazole
- carboxamide
- fluorophenyl
- chlorophenyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- -1 tetrahydrothiophene-3-yl Chemical group 0.000 claims 123
- 125000000217 alkyl group Chemical group 0.000 claims 86
- 125000005842 heteroatom Chemical group 0.000 claims 45
- 229910052760 oxygen Inorganic materials 0.000 claims 45
- 229910052717 sulfur Inorganic materials 0.000 claims 45
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 40
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 38
- 125000000753 cycloalkyl group Chemical group 0.000 claims 33
- 125000001072 heteroaryl group Chemical group 0.000 claims 32
- 125000003118 aryl group Chemical group 0.000 claims 28
- 125000005843 halogen group Chemical group 0.000 claims 27
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 20
- 125000000623 heterocyclic group Chemical group 0.000 claims 17
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 16
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 12
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims 9
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 8
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 6
- 201000001320 Atherosclerosis Diseases 0.000 claims 5
- 125000002950 monocyclic group Chemical group 0.000 claims 5
- 125000006661 (C4-C6) heterocyclic group Chemical group 0.000 claims 4
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 4
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 4
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- DQZNKQWAVMGUIN-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(2-hydroxycyclopentyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1C(CCC1)O)C1=CC=C(C=C1)F DQZNKQWAVMGUIN-UHFFFAOYSA-N 0.000 claims 2
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 230000007850 degeneration Effects 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- CVJHDHLEPSCDGR-HSZRJFAPSA-N 3-(2-chloro-5-cyanophenyl)-1-(4-fluorophenyl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=C(C=C1)C#N)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](C(C)C)CO)C1=CC=C(C=C1)F CVJHDHLEPSCDGR-HSZRJFAPSA-N 0.000 claims 1
- OZMDDFOOQFKYES-UHFFFAOYSA-N 3-(2-chloro-5-cyanophenyl)-1-(4-fluorophenyl)-N-[1-(hydroxymethyl)cyclobutyl]indazole-6-carboxamide Chemical compound ClC1=C(C=C(C=C1)C#N)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CCC1)CO)C1=CC=C(C=C1)F OZMDDFOOQFKYES-UHFFFAOYSA-N 0.000 claims 1
- AFZDSWYXAHLHGL-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1,1,1-trifluoro-2-hydroxyheptan-3-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CCCC)C(C(F)(F)F)O)C1=CC=C(C=C1)F AFZDSWYXAHLHGL-UHFFFAOYSA-N 0.000 claims 1
- CMDKQFAAXJYWIE-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1,2,5-thiadiazol-3-ylmethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC1=NSN=C1)C1=CC=C(C=C1)F CMDKQFAAXJYWIE-UHFFFAOYSA-N 0.000 claims 1
- AVRCLHVFFQEBPY-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1,2-oxazol-4-ylmethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC=1C=NOC=1)C1=CC=C(C=C1)F AVRCLHVFFQEBPY-UHFFFAOYSA-N 0.000 claims 1
- HJHQKMCAMDYDNE-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1-hydroxy-2-methylpropan-2-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CO)(C)C)C1=CC=C(C=C1)F HJHQKMCAMDYDNE-UHFFFAOYSA-N 0.000 claims 1
- XLIFNOAGNQUFBX-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1-hydroxy-3-methoxy-1-phenylpropan-2-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C(C1=CC=CC=C1)O)COC)C1=CC=C(C=C1)F XLIFNOAGNQUFBX-UHFFFAOYSA-N 0.000 claims 1
- WEFMHENNKAJEMB-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1-hydroxybutan-2-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CC)CO)C1=CC=C(C=C1)F WEFMHENNKAJEMB-UHFFFAOYSA-N 0.000 claims 1
- OYYOEXNYHFTCBP-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1-hydroxypropan-2-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CO)C)C1=CC=C(C=C1)F OYYOEXNYHFTCBP-UHFFFAOYSA-N 0.000 claims 1
- MCDBVFGXXHEQJP-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1-methyl-2-oxopyrrolidin-3-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1C(N(CC1)C)=O)C1=CC=C(C=C1)F MCDBVFGXXHEQJP-UHFFFAOYSA-N 0.000 claims 1
- ZUDAILDJDCCLGW-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1-methyl-5-oxopyrrolidin-3-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1CN(C(C1)=O)C)C1=CC=C(C=C1)F ZUDAILDJDCCLGW-UHFFFAOYSA-N 0.000 claims 1
- DJSPZVKTYANFJJ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(1-pyridin-2-ylpropan-2-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CC1=NC=CC=C1)C)C1=CC=C(C=C1)F DJSPZVKTYANFJJ-UHFFFAOYSA-N 0.000 claims 1
- ZJOLIZIWXRBNCC-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(2-hydroxy-1-phenylethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CO)C1=CC=CC=C1)C1=CC=C(C=C1)F ZJOLIZIWXRBNCC-UHFFFAOYSA-N 0.000 claims 1
- JWKSXTTXAYKCTH-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(2-hydroxy-5-methylcyclopentyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1C(CCC1C)O)C1=CC=C(C=C1)F JWKSXTTXAYKCTH-UHFFFAOYSA-N 0.000 claims 1
- XSZVJJFKPXZLRS-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(2-methoxyethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCOC)C1=CC=C(C=C1)F XSZVJJFKPXZLRS-UHFFFAOYSA-N 0.000 claims 1
- JSYKDXJJRYARSA-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(2-oxopyrrolidin-3-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1C(NCC1)=O)C1=CC=C(C=C1)F JSYKDXJJRYARSA-UHFFFAOYSA-N 0.000 claims 1
- YCFMIVNQCDCPNF-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(2-sulfamoylethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCS(N)(=O)=O)C1=CC=C(C=C1)F YCFMIVNQCDCPNF-UHFFFAOYSA-N 0.000 claims 1
- XBSWANVTTHJAJT-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(3-hydroxy-3,4-dihydro-2H-chromen-4-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1C(COC2=CC=CC=C12)O)C1=CC=C(C=C1)F XBSWANVTTHJAJT-UHFFFAOYSA-N 0.000 claims 1
- YIHNUNWNZXBXDQ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(3-hydroxycyclopentyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1CC(CC1)O)C1=CC=C(C=C1)F YIHNUNWNZXBXDQ-UHFFFAOYSA-N 0.000 claims 1
- FTEWBMRAKORYPE-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(3-morpholin-4-yl-1-phenylpropyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CCN1CCOCC1)C1=CC=CC=C1)C1=CC=C(C=C1)F FTEWBMRAKORYPE-UHFFFAOYSA-N 0.000 claims 1
- FMOWOPWZWWLPCP-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(3-oxocyclobutyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1CC(C1)=O)C1=CC=C(C=C1)F FMOWOPWZWWLPCP-UHFFFAOYSA-N 0.000 claims 1
- CSASAUOBCBTLHH-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(4,4,4-trifluoro-3-hydroxybutan-2-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C(C(F)(F)F)O)C)C1=CC=C(C=C1)F CSASAUOBCBTLHH-UHFFFAOYSA-N 0.000 claims 1
- NIVSDSCTVZNNAE-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(4-hydroxy-2-methylpentan-2-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CC(C)O)(C)C)C1=CC=C(C=C1)F NIVSDSCTVZNNAE-UHFFFAOYSA-N 0.000 claims 1
- DMIFRWVSDPBKEQ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(oxan-4-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1CCOCC1)C1=CC=C(C=C1)F DMIFRWVSDPBKEQ-UHFFFAOYSA-N 0.000 claims 1
- WRWWIBRHHZPZEE-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(oxetan-3-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1COC1)C1=CC=C(C=C1)F WRWWIBRHHZPZEE-UHFFFAOYSA-N 0.000 claims 1
- ZDSFICODFSGWOR-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(oxolan-3-yl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1COCC1)C1=CC=C(C=C1)F ZDSFICODFSGWOR-UHFFFAOYSA-N 0.000 claims 1
- MHWAPMGKMFYZIG-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(pyridin-2-ylmethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC1=NC=CC=C1)C1=CC=C(C=C1)F MHWAPMGKMFYZIG-UHFFFAOYSA-N 0.000 claims 1
- WLENMOJGBQBHRO-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(pyridin-3-ylmethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC=1C=NC=CC=1)C1=CC=C(C=C1)F WLENMOJGBQBHRO-UHFFFAOYSA-N 0.000 claims 1
- LBTXEEXPGCBAIM-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(pyridin-4-ylmethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC1=CC=NC=C1)C1=CC=C(C=C1)F LBTXEEXPGCBAIM-UHFFFAOYSA-N 0.000 claims 1
- OLWRXIQBQMXVST-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-(pyrimidin-5-ylmethyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC=1C=NC=NC=1)C1=CC=C(C=C1)F OLWRXIQBQMXVST-UHFFFAOYSA-N 0.000 claims 1
- CZJLQLVYHHQSMQ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1-hydroxycyclohexyl)methyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC1(CCCCC1)O)C1=CC=C(C=C1)F CZJLQLVYHHQSMQ-UHFFFAOYSA-N 0.000 claims 1
- CGRBGLIYVQSQLP-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1-hydroxycyclopropyl)methyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC1(CC1)O)C1=CC=C(C=C1)F CGRBGLIYVQSQLP-UHFFFAOYSA-N 0.000 claims 1
- MHAIAZMUAJUQLE-MRXNPFEDSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@H](C)C=1C=NC(=CC=1)C(F)(F)F)C1=CC=C(C=C1)F MHAIAZMUAJUQLE-MRXNPFEDSA-N 0.000 claims 1
- NXLFGBLFRUYQHC-QHCPKHFHSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1R)-2-hydroxy-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](CO)C=1C=NC(=CC=1)C(F)(F)F)C1=CC=C(C=C1)F NXLFGBLFRUYQHC-QHCPKHFHSA-N 0.000 claims 1
- YWQMVOJRMLTSCY-WRHNGFHOSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1R,2R)-1-hydroxy-1-phenylpropan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H]([C@@H](C1=CC=CC=C1)O)C)C1=CC=C(C=C1)F YWQMVOJRMLTSCY-WRHNGFHOSA-N 0.000 claims 1
- DQZNKQWAVMGUIN-GGAORHGYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1R,2S)-2-hydroxycyclopentyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@H]1[C@H](CCC1)O)C1=CC=C(C=C1)F DQZNKQWAVMGUIN-GGAORHGYSA-N 0.000 claims 1
- UATLWZPBFHUFFO-INIZCTEOSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1S)-1-(2-methylpyrimidin-5-yl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](C)C=1C=NC(=NC=1)C)C1=CC=C(C=C1)F UATLWZPBFHUFFO-INIZCTEOSA-N 0.000 claims 1
- ONNSYWJFONSNCL-HNNXBMFYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1S)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](C)C=1C=NC(=NC=1)C(F)(F)F)C1=CC=C(C=C1)F ONNSYWJFONSNCL-HNNXBMFYSA-N 0.000 claims 1
- MHAIAZMUAJUQLE-INIZCTEOSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](C)C=1C=NC(=CC=1)C(F)(F)F)C1=CC=C(C=C1)F MHAIAZMUAJUQLE-INIZCTEOSA-N 0.000 claims 1
- NXLFGBLFRUYQHC-HSZRJFAPSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1S)-2-hydroxy-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@H](CO)C=1C=NC(=CC=1)C(F)(F)F)C1=CC=C(C=C1)F NXLFGBLFRUYQHC-HSZRJFAPSA-N 0.000 claims 1
- YWQMVOJRMLTSCY-KWMCUTETSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H]([C@H](C1=CC=CC=C1)O)C)C1=CC=C(C=C1)F YWQMVOJRMLTSCY-KWMCUTETSA-N 0.000 claims 1
- DQZNKQWAVMGUIN-GMAHTHKFSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(1S,2S)-2-hydroxycyclopentyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H]1[C@H](CCC1)O)C1=CC=C(C=C1)F DQZNKQWAVMGUIN-GMAHTHKFSA-N 0.000 claims 1
- IHLUMLSKESFFBQ-CQSZACIVSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2R)-1-sulfamoylpropan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](CS(N)(=O)=O)C)C1=CC=C(C=C1)F IHLUMLSKESFFBQ-CQSZACIVSA-N 0.000 claims 1
- OQIZMLKSBKOUMM-HSZRJFAPSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](C(C)(C)C)CO)C1=CC=C(C=C1)F OQIZMLKSBKOUMM-HSZRJFAPSA-N 0.000 claims 1
- DUPVYISYNVJFAV-JOCHJYFZSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](C(C)C)CO)C1=CC=C(C=C1)F DUPVYISYNVJFAV-JOCHJYFZSA-N 0.000 claims 1
- DXKQZPINIXDTMS-QFIPXVFZSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]indazole-6-carboxamide Chemical compound C(C1=CC=CC=C1)[C@@H](CO)NC(=O)C1=CC=C2C(=NN(C2=C1)C1=CC=C(C=C1)F)C1=C(C=CC=C1)Cl DXKQZPINIXDTMS-QFIPXVFZSA-N 0.000 claims 1
- IJILNULXBJPPRZ-SFHVURJKSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S)-1-hydroxy-5-sulfanylpentan-2-yl]indazole-6-carboxamide Chemical compound OC[C@H](CCCS)NC(=O)C1=CC=C2C(=C1)N(N=C2C1=C(Cl)C=CC=C1)C1=CC=C(F)C=C1 IJILNULXBJPPRZ-SFHVURJKSA-N 0.000 claims 1
- OYYOEXNYHFTCBP-AWEZNQCLSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S)-1-hydroxypropan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@H](CO)C)C1=CC=C(C=C1)F OYYOEXNYHFTCBP-AWEZNQCLSA-N 0.000 claims 1
- HTPNPBVTLHZFSU-HNNXBMFYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S)-1-methoxypropan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@H](COC)C)C1=CC=C(C=C1)F HTPNPBVTLHZFSU-HNNXBMFYSA-N 0.000 claims 1
- WYWYBQBJVNPLPM-QMHKHESXSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S,3S)-1-hydroxy-3-methylpentan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H]([C@H](CC)C)CO)C1=CC=C(C=C1)F WYWYBQBJVNPLPM-QMHKHESXSA-N 0.000 claims 1
- QDIXESDTKRRDBX-OQLYEKFSSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[(2S,3S,4S,6S)-3-hydroxy-6-methoxy-2-methyloxan-4-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H]1[C@@H]([C@@H](O[C@@H](C1)OC)C)O)C1=CC=C(C=C1)F QDIXESDTKRRDBX-OQLYEKFSSA-N 0.000 claims 1
- OZKOHQFEZREGMZ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-(1H-imidazol-5-yl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)C=1N=CNC=1)C1=CC=C(C=C1)F OZKOHQFEZREGMZ-UHFFFAOYSA-N 0.000 claims 1
- KDMJVZPFSCKJHJ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-(4-methyl-1,2,4-triazol-3-yl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)C1=NN=CN1C)C1=CC=C(C=C1)F KDMJVZPFSCKJHJ-UHFFFAOYSA-N 0.000 claims 1
- MKOGKQAMAFFLPW-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)C1=NOC(=N1)C)C1=CC=C(C=C1)F MKOGKQAMAFFLPW-UHFFFAOYSA-N 0.000 claims 1
- DHBBMSXBHLZAEY-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-(hydroxymethyl)-2,3-dihydroinden-1-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CCC2=CC=CC=C12)CO)C1=CC=C(C=C1)F DHBBMSXBHLZAEY-UHFFFAOYSA-N 0.000 claims 1
- KFRZELCFLDVTGY-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-(hydroxymethyl)cyclobutyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CCC1)CO)C1=CC=C(C=C1)F KFRZELCFLDVTGY-UHFFFAOYSA-N 0.000 claims 1
- IMHPFEGSFFVKFC-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-(hydroxymethyl)cyclopentyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CCCC1)CO)C1=CC=C(C=C1)F IMHPFEGSFFVKFC-UHFFFAOYSA-N 0.000 claims 1
- DCVSPHXHTWDALG-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-(hydroxymethyl)cyclopropyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CC1)CO)C1=CC=C(C=C1)F DCVSPHXHTWDALG-UHFFFAOYSA-N 0.000 claims 1
- ONNSYWJFONSNCL-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)C=1C=NC(=NC=1)C(F)(F)F)C1=CC=C(C=C1)F ONNSYWJFONSNCL-UHFFFAOYSA-N 0.000 claims 1
- NYAGXMSTGUCZOO-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[2-(1,2,4-triazol-4-yl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCN1C=NN=C1)C1=CC=C(C=C1)F NYAGXMSTGUCZOO-UHFFFAOYSA-N 0.000 claims 1
- OBTLICBCPYFGNU-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[2-(1-methylpyrazol-4-yl)propan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)(C=1C=NN(C=1)C)C)C1=CC=C(C=C1)F OBTLICBCPYFGNU-UHFFFAOYSA-N 0.000 claims 1
- NCICWTSOSRBMPB-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[2-(phenylsulfamoyl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCS(NC1=CC=CC=C1)(=O)=O)C1=CC=C(C=C1)F NCICWTSOSRBMPB-UHFFFAOYSA-N 0.000 claims 1
- FFOVYRRKGQVBLQ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[2-(pyridin-2-ylsulfamoyl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCS(NC1=NC=CC=C1)(=O)=O)C1=CC=C(C=C1)F FFOVYRRKGQVBLQ-UHFFFAOYSA-N 0.000 claims 1
- VZGAHTDOGIWOBW-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[2-[6-(trifluoromethyl)pyridin-3-yl]propan-2-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)(C=1C=NC(=CC=1)C(F)(F)F)C)C1=CC=C(C=C1)F VZGAHTDOGIWOBW-UHFFFAOYSA-N 0.000 claims 1
- CHYMTBONAVOAFY-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[3-(hydroxymethyl)thiolan-3-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CSCC1)CO)C1=CC=C(C=C1)F CHYMTBONAVOAFY-UHFFFAOYSA-N 0.000 claims 1
- HROARXLLVHOWHL-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[4-(2-hydroxypropan-2-yl)oxan-4-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CCOCC1)C(C)(C)O)C1=CC=C(C=C1)F HROARXLLVHOWHL-UHFFFAOYSA-N 0.000 claims 1
- NKLWVVJGBRUJTR-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[4-(hydroxymethyl)oxan-4-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CCOCC1)CO)C1=CC=C(C=C1)F NKLWVVJGBRUJTR-UHFFFAOYSA-N 0.000 claims 1
- GHCDISMHZQFCQQ-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[6-(trifluoromethyl)pyridin-3-yl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC=1C=NC(=CC=1)C(F)(F)F)C1=CC=C(C=C1)F GHCDISMHZQFCQQ-UHFFFAOYSA-N 0.000 claims 1
- QMZZSICLUMVALU-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[[2-(trifluoromethyl)pyrimidin-5-yl]methyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC=1C=NC(=NC=1)C(F)(F)F)C1=CC=C(C=C1)F QMZZSICLUMVALU-UHFFFAOYSA-N 0.000 claims 1
- YQDHZUWVGKQQGY-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCC=1C=NC(=CC=1)C(F)(F)F)C1=CC=C(C=C1)F YQDHZUWVGKQQGY-UHFFFAOYSA-N 0.000 claims 1
- NMRQXZDVXUHBNG-UHFFFAOYSA-N 3-(2-chlorophenyl)-1-(4-fluorophenyl)-N-methyl-N-[1-(3-phenyl-1H-pyrazol-5-yl)ethyl]indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)N(C(C)C1=NNC(=C1)C1=CC=CC=C1)C)C1=CC=C(C=C1)F NMRQXZDVXUHBNG-UHFFFAOYSA-N 0.000 claims 1
- WAKJJYUFDKAGKA-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-(1,3-dihydroxy-1-phenylpropan-2-yl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C(C1=CC=CC=C1)O)CO)C1=CC=C(C=C1)F WAKJJYUFDKAGKA-UHFFFAOYSA-N 0.000 claims 1
- XDQCOAIQZQDMOP-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-(1,3-dihydroxy-2-methylpropan-2-yl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CO)(C)CO)C1=CC=C(C=C1)F XDQCOAIQZQDMOP-UHFFFAOYSA-N 0.000 claims 1
- YDTWYYDEMILEQX-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-(1-cyanocyclopropyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1(CC1)C#N)C1=CC=C(C=C1)F YDTWYYDEMILEQX-UHFFFAOYSA-N 0.000 claims 1
- FESYBIMZWZFWFG-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-(1-cyclopropyl-2-hydroxyethyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CO)C1CC1)C1=CC=C(C=C1)F FESYBIMZWZFWFG-UHFFFAOYSA-N 0.000 claims 1
- VPKJQZHSZNSWSA-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-(2,5-dioxopyrrolidin-3-yl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1C(NC(C1)=O)=O)C1=CC=C(C=C1)F VPKJQZHSZNSWSA-UHFFFAOYSA-N 0.000 claims 1
- RORZKYLORXWEGA-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-(2-ethylsulfonylethyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCS(=O)(=O)CC)C1=CC=C(C=C1)F RORZKYLORXWEGA-UHFFFAOYSA-N 0.000 claims 1
- BBFSJSUYOANEJF-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-(3,3-difluorocyclopentyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1CC(CC1)(F)F)C1=CC=C(C=C1)F BBFSJSUYOANEJF-UHFFFAOYSA-N 0.000 claims 1
- HGFZAVZHQAIJQK-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(CO)(CO)CO)C1=CC=C(C=C1)F HGFZAVZHQAIJQK-UHFFFAOYSA-N 0.000 claims 1
- KZONCETYRYSSPO-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-[1-(3,5-dimethyl-1H-pyrazol-4-yl)ethyl]-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)C=1C(=NNC=1C)C)C1=CC=C(C=C1)F KZONCETYRYSSPO-UHFFFAOYSA-N 0.000 claims 1
- WSEYUGGCUNSEQV-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-[2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1C(C(C(C1)CO)O)O)C1=CC=C(C=C1)F WSEYUGGCUNSEQV-UHFFFAOYSA-N 0.000 claims 1
- AHLQEYDKHLLLIK-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-[2-(cyclohexylsulfamoyl)ethyl]-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCS(NC1CCCCC1)(=O)=O)C1=CC=C(C=C1)F AHLQEYDKHLLLIK-UHFFFAOYSA-N 0.000 claims 1
- AZZPIOUSFZCVSM-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-[2-(dimethylsulfamoyl)ethyl]-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCS(N(C)C)(=O)=O)C1=CC=C(C=C1)F AZZPIOUSFZCVSM-UHFFFAOYSA-N 0.000 claims 1
- ZYCYKDVXQZXIRJ-UHFFFAOYSA-N 3-(2-chlorophenyl)-N-cyclopentyl-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1CCCC1)C1=CC=C(C=C1)F ZYCYKDVXQZXIRJ-UHFFFAOYSA-N 0.000 claims 1
- MUJNGTVHCAGXGH-HSZRJFAPSA-N 3-(3-cyclopropylphenyl)-1-(5-fluoropyridin-2-yl)-N-[(2S)-1-hydroxy-3-methylbutan-2-yl]indazole-6-carboxamide Chemical compound C1(CC1)C=1C=C(C=CC=1)C1=NN(C2=CC(=CC=C12)C(=O)N[C@@H](C(C)C)CO)C1=NC=C(C=C1)F MUJNGTVHCAGXGH-HSZRJFAPSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 1
- FZAXBPZVVJOFKX-UHFFFAOYSA-N 3-methyl-1,2,4-oxadiazole Chemical compound CC=1N=CON=1 FZAXBPZVVJOFKX-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims 1
- 102100035762 Diacylglycerol O-acyltransferase 2 Human genes 0.000 claims 1
- 101000930020 Homo sapiens Diacylglycerol O-acyltransferase 2 Proteins 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- DJAJMZKSTOWNGX-UHFFFAOYSA-N N-(1-amino-3-methyl-1-oxobutan-2-yl)-3-(2-chlorophenyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound C(N)(=O)C(C(C)C)NC(=O)C1=CC=C2C(=NN(C2=C1)C1=CC=C(C=C1)F)C1=C(C=CC=C1)Cl DJAJMZKSTOWNGX-UHFFFAOYSA-N 0.000 claims 1
- QBJQDISOOJOFLZ-UHFFFAOYSA-N N-[1-(4-bromophenyl)-3-hydroxycyclobutyl]-3-(2-chlorophenyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound BrC1=CC=C(C=C1)C1(CC(C1)O)NC(=O)C1=CC=C2C(=NN(C2=C1)C1=CC=C(C=C1)F)C1=C(C=CC=C1)Cl QBJQDISOOJOFLZ-UHFFFAOYSA-N 0.000 claims 1
- DJIAWPGMWFKRBF-UHFFFAOYSA-N N-[2-(benzylsulfamoyl)ethyl]-3-(2-chlorophenyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound C(C1=CC=CC=C1)NS(=O)(=O)CCNC(=O)C1=CC=C2C(=NN(C2=C1)C1=CC=C(C=C1)F)C1=C(C=CC=C1)Cl DJIAWPGMWFKRBF-UHFFFAOYSA-N 0.000 claims 1
- GZKQGJPIXSPAFZ-UHFFFAOYSA-N N-tert-butyl-3-(2-chlorophenyl)-1-(4-fluorophenyl)indazole-6-carboxamide Chemical compound C(C)(C)(C)NC(=O)C1=CC=C2C(=NN(C2=C1)C1=CC=C(C=C1)F)C1=C(C=CC=C1)Cl GZKQGJPIXSPAFZ-UHFFFAOYSA-N 0.000 claims 1
- 230000008485 antagonism Effects 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- YMGUBTXCNDTFJI-UHFFFAOYSA-M cyclopropanecarboxylate Chemical compound [O-]C(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-M 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002440 hepatic effect Effects 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- VNBOJBFXSURHRL-UHFFFAOYSA-N tert-butyl 3-[[3-(2-chlorophenyl)-1-(4-fluorophenyl)indazole-6-carbonyl]amino]-4-hydroxypyrrolidine-1-carboxylate Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC1CN(CC1O)C(=O)OC(C)(C)C)C1=CC=C(C=C1)F VNBOJBFXSURHRL-UHFFFAOYSA-N 0.000 claims 1
- WCHZETLLPCMELH-UHFFFAOYSA-N tert-butyl 3-[[3-(2-chlorophenyl)-1-(4-fluorophenyl)indazole-6-carbonyl]amino]propanoate Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NCCC(=O)OC(C)(C)C)C1=CC=C(C=C1)F WCHZETLLPCMELH-UHFFFAOYSA-N 0.000 claims 1
- VALOLBOVOFJSBX-UHFFFAOYSA-N tert-butyl 4-[1-[[3-(2-chlorophenyl)-1-(4-fluorophenyl)indazole-6-carbonyl]amino]ethyl]imidazole-1-carboxylate Chemical compound ClC1=C(C=CC=C1)C1=NN(C2=CC(=CC=C12)C(=O)NC(C)C=1N=CN(C=1)C(=O)OC(C)(C)C)C1=CC=C(C=C1)F VALOLBOVOFJSBX-UHFFFAOYSA-N 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662424066P | 2016-11-18 | 2016-11-18 | |
| US62/424,066 | 2016-11-18 | ||
| PCT/US2017/061223 WO2018093696A1 (en) | 2016-11-18 | 2017-11-13 | Indazole derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502058A JP2020502058A (ja) | 2020-01-23 |
| JP2020502058A5 true JP2020502058A5 (enExample) | 2020-10-22 |
Family
ID=62145755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019526217A Ceased JP2020502058A (ja) | 2016-11-18 | 2017-11-13 | ジアシルグリセリドｏ−アシルトランスフェラーゼ２の阻害薬として有用なインダゾール誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11104690B2 (enExample) |
| EP (1) | EP3541374A4 (enExample) |
| JP (1) | JP2020502058A (enExample) |
| KR (1) | KR20190078646A (enExample) |
| CN (1) | CN110121341A (enExample) |
| AU (1) | AU2017360939B2 (enExample) |
| BR (1) | BR112019010164A2 (enExample) |
| CA (1) | CA3043203A1 (enExample) |
| MA (1) | MA46856A (enExample) |
| MX (1) | MX2019005786A (enExample) |
| RU (1) | RU2019117556A (enExample) |
| WO (1) | WO2018093696A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41179A (fr) | 2014-12-19 | 2017-10-24 | Cancer Research Tech Ltd | Composés inhibiteurs de parg |
| US11787810B2 (en) * | 2020-05-18 | 2023-10-17 | Merck Sharp & Dohme Llc | Diacylglyceride O-acyltransferase 2 inhibitors |
| PT4225739T (pt) * | 2020-10-08 | 2026-04-07 | Merck Sharp & Dohme Llc | Preparação de derivados de benzimidazolona como novos inibidores da diacilglicerol o-aciltransferase 2 |
| TW202229232A (zh) | 2020-10-08 | 2022-08-01 | 美商默沙東藥廠 | 作為新穎二醯基甘油酯o-醯基轉移酶2抑制劑之吲哚酮衍生物的製備 |
| EP4255904A2 (en) * | 2020-12-03 | 2023-10-11 | Domain Therapeutics | Novel par-2 inhibitors |
| WO2022140169A1 (en) * | 2020-12-22 | 2022-06-30 | Merck Sharp & Dohme Corp. | Preparation of tetrahydroindazole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors |
| AR128846A1 (es) | 2022-03-23 | 2024-06-19 | Ideaya Biosciences Inc | Compuestos de indazol sustituidos con piperazina como inhibidores de parg |
| KR20250107197A (ko) * | 2022-11-01 | 2025-07-11 | 머크 샤프 앤드 돔 엘엘씨 | 신규 디아실글리세리드 o-아실트랜스퍼라제 2 억제제로서의 피라졸로피리딘 및 트리아졸로피리딘 유도체의 제조 |
| IL321166A (en) | 2022-12-02 | 2025-07-01 | Merck Sharp & Dohme Llc | Preparation of fused azole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors |
| WO2025247370A1 (zh) * | 2024-06-01 | 2025-12-04 | 中国药科大学 | 双环类化合物及其医药用途 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL332187A1 (en) | 1996-09-04 | 1999-08-30 | Pfizer | Substitution derivatives of indazole and their application as inhibitors of phosphodiesterase (pde) of iv type and tumor necrosis factor (tnf) |
| WO1998039342A1 (en) | 1997-03-07 | 1998-09-11 | Metabasis Therapeutics, Inc. | Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
| WO1998039344A1 (en) | 1997-03-07 | 1998-09-11 | Metabasis Therapeutics, Inc. | Novel purine inhibitors of fructose-1,6-bisphosphatase |
| ZA981936B (en) | 1997-03-07 | 1999-09-06 | Metabasis Therapeutics Inc | Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase. |
| WO2000014095A1 (en) | 1998-09-09 | 2000-03-16 | Metabasis Therapeutics, Inc. | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| JP2004513076A (ja) | 2000-07-25 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | 糖尿病治療で有用なｎ−置換インドール類 |
| US6852738B2 (en) | 2001-01-30 | 2005-02-08 | Merck & Co., Inc. | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| US6596718B1 (en) * | 2001-11-27 | 2003-07-22 | Hoffmann-La Roche Inc. | 7-Morpholin-4yl-benzothiazole amide derivatives |
| AR040241A1 (es) | 2002-06-10 | 2005-03-23 | Merck & Co Inc | Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia |
| NZ538031A (en) | 2002-08-29 | 2007-10-26 | Merck & Co Inc | Indoles having anti-diabetic activity |
| JP4340232B2 (ja) | 2002-08-29 | 2009-10-07 | メルク エンド カムパニー インコーポレーテッド | 抗糖尿病活性を有するインドール類 |
| WO2004066963A2 (en) | 2003-01-17 | 2004-08-12 | Merck & Co., Inc. | N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| WO2007084413A2 (en) | 2004-07-14 | 2007-07-26 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| EP1771169A1 (en) | 2004-07-14 | 2007-04-11 | PTC Therapeutics, Inc. | Methods for treating hepatitis c |
| WO2006117314A2 (en) | 2005-04-30 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Novel piperidin- substituted indoles and their use as ccr-3 modulators |
| WO2007084435A2 (en) | 2006-01-13 | 2007-07-26 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| EP2044055A4 (en) * | 2006-07-21 | 2011-03-23 | Takeda Pharmaceutical | amide compounds |
| US7514433B2 (en) | 2006-08-03 | 2009-04-07 | Hoffmann-La Roche Inc. | 1H-indole-6-yl-piperazin-1-yl-methanone derivatives |
| US8138197B2 (en) | 2007-01-12 | 2012-03-20 | Msd K.K. | Spirochromanon derivatives |
| EP2174343A1 (en) | 2007-06-28 | 2010-04-14 | Semiconductor Energy Laboratory Co, Ltd. | Manufacturing method of semiconductor device |
| CA2691010A1 (en) | 2007-06-28 | 2008-12-31 | Merck Frosst Canada Ltd. | Substituted fused pyrimidines as antagonists of gpr105 activity |
| DE102007032507A1 (de) * | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
| WO2009042053A2 (en) | 2007-09-21 | 2009-04-02 | Merck & Co., Inc. | Neuromedin u receptor agonists and uses thereof |
| US8461185B2 (en) | 2007-10-31 | 2013-06-11 | Merck Sharp & Dohme Corp. | P2X3 receptor antagonists for treatment of pain |
| JP2011502148A (ja) | 2007-10-31 | 2011-01-20 | メルク・シャープ・エンド・ドーム・コーポレイション | 疼痛の治療用としてのｐ２ｘ３受容体アンタゴニスト |
| US8598209B2 (en) | 2008-10-31 | 2013-12-03 | Merck Sharp & Dohme Corp. | P2X3, receptor antagonists for treatment of pain |
| EP2210891A1 (en) | 2009-01-26 | 2010-07-28 | Domain Therapeutics | New adenosine receptor ligands and uses thereof |
| US20120022057A1 (en) | 2009-03-18 | 2012-01-26 | Schering Corporation | Bicyclic compounds as inhibitors of diacyglycerol acyltransferase |
| AU2010229142A1 (en) | 2009-03-23 | 2011-10-13 | Merck Sharp & Dohme Corp. | P2X3, receptor antagonists for treatment of pain |
| US8946231B2 (en) | 2009-03-23 | 2015-02-03 | Merck Sharp & Dohme Corp. | P2X3, receptor antagonists for treatment of pain |
| ES2660892T3 (es) * | 2009-03-23 | 2018-03-26 | Merck Sharp & Dohme Corp. | Antagonistas del receptor P2X3 para el tratamiento del dolor |
| US8927576B2 (en) | 2009-04-06 | 2015-01-06 | PTC Therpeutics, Inc. | HCV inhibitor and therapeutic agent combinations |
| WO2014026329A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof |
| US10568876B2 (en) | 2014-09-05 | 2020-02-25 | Merck Sharp & Dohme Corp. | Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 |
| US9877957B2 (en) | 2014-09-05 | 2018-01-30 | Merck Sharp & Dohme Corp. | Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 |
| US9828369B2 (en) | 2014-09-05 | 2017-11-28 | Merck Sharpe & Dohme Corp. | Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 |
| EP3298001B1 (en) | 2015-05-20 | 2020-05-13 | Eli Lilly and Company | Dgat2 inhibitors |
-
2017
- 2017-11-13 KR KR1020197016983A patent/KR20190078646A/ko not_active Withdrawn
- 2017-11-13 BR BR112019010164A patent/BR112019010164A2/pt not_active IP Right Cessation
- 2017-11-13 JP JP2019526217A patent/JP2020502058A/ja not_active Ceased
- 2017-11-13 MA MA046856A patent/MA46856A/fr unknown
- 2017-11-13 RU RU2019117556A patent/RU2019117556A/ru unknown
- 2017-11-13 MX MX2019005786A patent/MX2019005786A/es unknown
- 2017-11-13 US US16/461,902 patent/US11104690B2/en active Active
- 2017-11-13 WO PCT/US2017/061223 patent/WO2018093696A1/en not_active Ceased
- 2017-11-13 CA CA3043203A patent/CA3043203A1/en not_active Abandoned
- 2017-11-13 AU AU2017360939A patent/AU2017360939B2/en not_active Expired - Fee Related
- 2017-11-13 CN CN201780071343.9A patent/CN110121341A/zh active Pending
- 2017-11-13 EP EP17871593.4A patent/EP3541374A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019117556A (ru) | Индазольные производные, пригодные в качестве ингибиторов диацилглицерид o-ацилтрансферазы 2 | |
| RU2017124425A (ru) | Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg | |
| RU2485114C2 (ru) | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов | |
| RU2452738C2 (ru) | Соединения, модулирующие активность c-fms и/или c-kit, и их применения | |
| JP2020506946A5 (enExample) | ||
| JP2023506642A5 (enExample) | ||
| RU2017125520A (ru) | Соединения, ингибирующие parg | |
| JP5687903B2 (ja) | キヌレニン産生抑制剤 | |
| JP2019533694A5 (enExample) | ||
| HRP20212000T1 (hr) | Aminotriazolopiridini kao inhibitori kinaze | |
| RU2017121044A (ru) | Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы | |
| JP2017538750A5 (enExample) | ||
| JP2010533158A5 (enExample) | ||
| JP2016523911A5 (enExample) | ||
| JP2021535134A5 (enExample) | ||
| RU2021127810A (ru) | Замещенные гетероарилом пиридины и способы применения | |
| JP2018535999A5 (enExample) | ||
| HRP20191327T1 (hr) | 4-hidroksi-3-(heteroaril)piridin-2-on apj agonisti za primjenju u liječenju kardiovaskularnih poremećaja | |
| JP2019518036A5 (enExample) | ||
| JP2018530591A5 (enExample) | ||
| JP2017537948A5 (enExample) | ||
| JP2021511363A5 (enExample) | ||
| RU2016141646A (ru) | Ингибиторы trka киназы, основанные на них композиции и способы | |
| JP2019509319A5 (enExample) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik |